Related Experiment Video
Updated: Jun 19, 2026

Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in
Sajiv Chandradas1, Gintaras Deikus, Jonathan G Tardos
1Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.
Abstract:
Following recruitment to solid tissues, peripheral blood monocytes express a number of proinflammatory molecules including TF, a trigger of coagulation that also promotes cell-cell interactions and tissue remodeling. Monocytes express two forms of TF: flTF, a highly coagulant transmembrane form, and asTF, a highly proangiogenic, soluble TF form. Biosynthesis of the two TF forms occurs via alternative processing of exon 5 during pre-mRNA splicing. Its inclusion results in flTF mRNA and its exclusion, asTF mRNA. We developed a splicing reporter system recently and determined that two spliceosomal constituents, SR proteins ASF/SF2 and SRp55, play a pivotal role in exon 5 inclusion. In this report, we show for the first time that two other SR proteins expressed in human monocytes, SRp40 and SC35, antagonize ASF/SF2 and SRp55 by competing for binding to certain sites in exon 5, thereby promoting TF exon 5 exclusion, an event unique to asTF biosynthesis. We also show that the intron preceding TF exon 5 possesses characteristics rarely found in U2 introns. Our findings indicate that modulation of TF pre-mRNA splicing can be accomplished via modification of SR proteins' activity, facilitating development of novel therapeutic strategies to modulate the "TF profile" of monocytes/macrophages.
Insights
Researchers identified key proteins that control tissue factor (TF) production in monocytes. Modulating these splicing factors could lead to new therapies for TF-related conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Peripheral blood monocytes express tissue factor (TF), a molecule involved in coagulation, inflammation, and tissue remodeling.
- Two forms of TF exist: full-length transmembrane TF (flTF) and alternatively spliced soluble TF (asTF).
- TF biosynthesis is regulated by alternative pre-mRNA splicing of exon 5.
Purpose of the Study:
- To investigate the role of SR proteins in regulating TF exon 5 splicing in human monocytes.
- To identify specific SR proteins that promote or inhibit TF exon 5 inclusion.
- To understand the unique characteristics of the intron preceding TF exon 5.
Main Methods:
- Development of a splicing reporter system to study TF pre-mRNA splicing.
- Analysis of SR protein binding sites within TF exon 5.
- Characterization of the intron preceding TF exon 5.
Main Results:
- SR proteins ASF/SF2 and SRp55 promote TF exon 5 inclusion, leading to flTF production.
- SR proteins SRp40 and SC35 antagonize ASF/SF2 and SRp55, promoting TF exon 5 exclusion and asTF production.
- The intron preceding TF exon 5 exhibits unusual characteristics for U2 introns.
Conclusions:
- SR protein activity can be modulated to control TF pre-mRNA splicing.
- Targeting SR proteins offers a potential therapeutic strategy to modulate the TF profile in monocytes/macrophages.
- Findings provide insights into the regulation of alternative splicing in immune cells.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
TGF - β Signaling Pathway
General Transcription Factors

